Sept 20 (Reuters) - InDex Pharmaceuticals Holding AB :
* SAID ON THURSDAY IT HAS COMPLETED A DIRECTED SHARE ISSUE OF APPROXIMATELY SEK 140 MILLION (USD 14 MILLION)
* THE NET PROCEEDS OF THE DIRECTED SHARE ISSUE ARE INTENDED TO BE USED TO ADVANCE THE COMPANY’S LEAD DRUG CANDIDATE, COBITOLIMOD, TOWARDS PHASE III
Source text for Eikon:
Further company coverage:
Gdynia Newsroom
Our Standards: The Thomson Reuters Trust Principles.